Aldeyra Therapeutics
ALDX
108 hedge funds and large institutions have $377M invested in Aldeyra Therapeutics in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 21 closing their positions.
143% more capital invested
Capital invested by funds: $155M → $377M (+$222M)
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
52% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 21
29% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 24
10% more funds holding
Funds holding: 98 → 108 (+10)
9.43% more ownership
Funds ownership: 57.71% → 67.13% (+9.4%)
16% less call options, than puts
Call options by funds: $4.16M | Put options by funds: $4.95M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$30.2M |
| 2 |
PA
Perceptive Advisors
New York
|
+$27.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$27.7M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$12.9M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$8.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$12.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.89M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$5.01M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.44M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.93M |
ALDX Hedge Fund Activity: Q1 2021 in Review
108 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q1 2021, worth a combined $377M — up 143% from $155M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ALDX positions and 21 closed out — a net gain of 11 holders — while 31 added to existing stakes and 24 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $30.2M. The largest seller was Citadel Advisors, cutting an estimated $12.3M.
- 108 institutional investors held Aldeyra Therapeutics (ALDX) as of Q1 2021, up from 98 in Q4 2020.
- Funds reported $377M of Aldeyra Therapeutics stock for Q1 2021, up 143% quarter-over-quarter.
- 32 funds opened new Aldeyra Therapeutics positions in Q1 2021 and 21 closed out, a net change of +11 holders.
- The largest Aldeyra Therapeutics buyer in Q1 2021 was First Light Asset Management, an estimated $30.2M added.
- The largest Aldeyra Therapeutics seller in Q1 2021 was Citadel Advisors, an estimated $12.3M sold.
Based on aggregated 13F filings for Q1 2021.